Clinicopatological features and outcome of breast cancer in CHEK2 germline mutation carriers

被引：0
|
作者：
Schlosser, Shir
Molho, Rinat Bernstein
Karminsky, Natalia
Barsuk, Daphna
Goldberg, Yael
Friedman, Eitan
Yerushalmi, Rinat
Drumea, Keren
Kedar, Inbal
Jiveliouk, Irina
Ben David, Merav Akiva
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P2-09-16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-09-16
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers
    Toss, Angela
    Tenedini, Elena
    Piombino, Claudia
    Venturelli, Marta
    Marchi, Isabella
    Gasparini, Elisa
    Barbieri, Elena
    Razzaboni, Elisabetta
    Domati, Federica
    Caggia, Federica
    Grandi, Giovanni
    Combi, Francesca
    Tazzioli, Giovanni
    Dominici, Massimo
    Tagliafico, Enrico
    Cortesi, Laura
    GENES, 2021, 12 (05)
  • [2] Clinical and Pathological Features of CHEK2 Mutation Carriers in Breast Cancer
    Lloyd, Christopher
    Rocha, Heather
    Ortiz, Nicole
    Mehr, Chelsea
    LABORATORY INVESTIGATION, 2023, 103 (03) : S174 - S175
  • [3] Breast cancer in Slovene CHEK2 mutation carriers
    Blatnik, A.
    Strojnik, K.
    Stegel, V.
    Drago, V. Etrajcic
    Klancar, G.
    Novakovic, S.
    Krajc, M.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 412 - 412
  • [4] Risk of HER2-positive breast cancer among germline CHEK2 mutation carriers with breast cancer
    Ramamurthy, Chethan
    Shameem, Raji
    Forman, Andrea
    Dolinsky, Jill S.
    Speare, Virginia
    McFarland, Rachel E.
    Ei-Deiry, Wafik S.
    Hall, Michael J.
    Daly, Mary Beryl
    Goldstein, Lori J.
    Obeid, Elias
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] Excess Risk for Contralateral Breast Cancer in CHEK2*1100delC Germline Mutation Carriers
    Annegien Broeks
    Lot de Witte
    Anke Nooijen
    Angelina Huseinovic
    Jan G.M. Klijn
    Flora E. van Leeuwen
    Nicola S. Russell
    Laura J. van't Veer
    Breast Cancer Research and Treatment, 2004, 83 : 91 - 93
  • [6] Performance of Breast Cancer Polygenic Risk Scores in 760 Female CHEK2 Germline Mutation Carriers
    Borde, Julika
    Ernst, Corinna
    Wappenschmidt, Barbara
    Niederacher, Dieter
    Weber-Lassalle, Konstantin
    Schmidt, Gunnar
    Hauke, Jan
    Quante, Anne S.
    Weber-Lassalle, Nana
    Horvath, Judit
    Pohl-Rescigno, Esther
    Arnold, Norbert
    Rump, Andreas
    Gehrig, Andrea
    Hentschel, Julia
    Faust, Ulrike
    Dutrannoy, Veronique
    Meindl, Alfons
    Kuzyakova, Maria
    Wang-Gohrke, Shan
    Weber, Bernhard H. F.
    Sutter, Christian
    Volk, Alexander E.
    Giannakopoulou, Olga
    Lee, Andrew
    Engel, Christoph
    Schmidt, Marjanka K.
    Antoniou, Antonis C.
    Schmutzler, Rita K.
    Kuchenbaecker, Karoline
    Hahnen, Eric
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (07): : 893 - 899
  • [7] Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers
    Broeks, A
    de Witte, L
    Nooijen, A
    Huseinovic, A
    Klijn, JGM
    van Leeuwen, FE
    Russell, NS
    van't Veer, LJ
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 83 (01) : 91 - 93
  • [8] CHEK2 gene somatic loss in breast tumors from carriers of germline CHEK2 mutations
    Iyevleva, A.
    Aleksakhina, S.
    Sokolenko, A.
    Baskina, S.
    Venina, A.
    Anisimova, E.
    Bizin, I. V.
    Ivantsov, A. O.
    Imyanitov, E. N.
    ANNALS OF ONCOLOGY, 2021, 32 : S1232 - S1232
  • [9] The landscape of somatic genetic alterations in breast cancers from CHEK2 germline mutation carriers
    Kumar, R.
    Pei, X.
    Selenica, P.
    Wen, H. Y.
    Powell, S.
    Robson, M.
    Riaz, N.
    Reis-Filho, J. S.
    Weigelt, B.
    Mandelker, D.
    CANCER RESEARCH, 2019, 79 (04)
  • [10] The Landscape of Somatic Genetic Alterations in Breast Cancers from CHEK2 Germline Mutation Carriers
    Mandelker, Diana
    Kumar, Rahul
    Pei, Xin
    Selenica, Pier
    Setton, Jeremy
    Arunachalam, Sasi
    Ceyhan-Birsoy, Ozge
    Brown, David N.
    Norton, Larry
    Robson, Mark E.
    Wen, Hannah Y.
    Powell, Simon
    Riaz, Nadeem
    Weigelt, Britta
    Reis-Filho, Jorge S.
    JNCI CANCER SPECTRUM, 2019, 3 (02)
12345